Get the Stockscreener App
11.90
2.95%
0.36
Exagen Inc stock is traded at $11.90, with a volume of 65,405.
It is up +2.95% in the last 24 hours and up +27.60% over the past month.
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
See More
Previous Close:
$11.54
Open:
$11.65
24h Volume:
65,405
Relative Volume:
0.23
Market Cap:
$261.40M
Revenue:
$52.55M
Net Income/Loss:
$-23.69M
P/E Ratio:
-12.66
EPS:
-0.94
Net Cash Flow:
$-15.29M
1W Performance:
+8.20%
1M Performance:
+27.60%
6M Performance:
+169.39%
1Y Performance:
+340.00%
1-Day Range:
$11.56
$11.90
1-Week Range:
$10.78
$11.90
52-Week Range:
$2.38
$11.90
Exagen Inc Stock (XGN) Company Profile
Name
Exagen Inc
Sector
Industry
Phone
(760) 560-1501
Address
1261 LIBERTY WAY, VISTA, CA
Compare XGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XGN
Exagen Inc
|
11.88 | 253.92M | 52.55M | -23.69M | -15.29M | -0.94 |
|
TMO
Thermo Fisher Scientific Inc
|
530.42 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
208.69 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
641.21 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
139.40 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.12 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Exagen Inc Stock (XGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-11-25 | Initiated | B. Riley Securities | Buy |
| Jul-30-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jul-23-25 | Initiated | Craig Hallum | Buy |
| Aug-05-22 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Apr-15-21 | Initiated | Canaccord Genuity | Buy |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Jun-02-20 | Resumed | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cantor Fitzgerald | Overweight |
| Oct-14-19 | Initiated | Cowen | Outperform |
| Oct-14-19 | Initiated | William Blair | Outperform |
View All
Exagen Inc Stock (XGN) Latest News
Has Exagen Inc. formed a bullish divergenceJuly 2025 Analyst Calls & Fast Entry High Yield Tips - newser.com
Strategies to average down on Exagen Inc.July 2025 Technicals & Technical Pattern Alert System - newser.com
Exagen (XGN) Gets Maintained 'Overweight' Rating by Keybanc Anal - GuruFocus
Detecting support and resistance levels for Exagen Inc.Rate Hike & Low Drawdown Investment Strategies - newser.com
How to build a custom watchlist for Exagen Inc.Price Action & Safe Investment Capital Preservation Plans - newser.com
Will Exagen Inc. benefit from macro trendsQuarterly Portfolio Report & Weekly Setup with ROI Potential - newser.com
How Exagen Inc. stock compares to market leadersPortfolio Return Summary & Expert Approved Momentum Trade Ideas - newser.com
Will Exagen Inc. stock split attract more investorsEarnings Miss & Daily Volume Surge Trade Alerts - newser.com
Will Exagen Inc. stock recover faster than peersMarket Trend Report & Intraday High Probability Setup Alerts - newser.com
What to do if you’re stuck in Exagen Inc.Watch List & Verified Technical Trade Signals - newser.com
Should you hold or exit Exagen Inc. nowJuly 2025 Trade Ideas & Real-Time Volume Trigger Notifications - newser.com
Analyzing Exagen Inc. with multi timeframe chartsMarket Sentiment Summary & Smart Investment Allocation Tips - newser.com
Earnings visualization tools for Exagen Inc.Market Risk Analysis & High Return Stock Watch Alerts - newser.com
Custom strategy builders for tracking Exagen Inc.Trade Exit Summary & Daily Technical Stock Forecast Reports - newser.com
Will Exagen Inc. stock maintain momentum in 20252025 Market Sentiment & Safe Entry Zone Tips - newser.com
Is Exagen Inc. (E08A) stock testing key supportJuly 2025 Levels & Real-Time Chart Breakout Alerts - newser.com
Exagen’s (XGN) “Sell (D-)” Rating Reiterated at Weiss Ratings - Defense World
Is Exagen Inc. stock ready for a breakoutInflation Watch & Weekly Stock Breakout Alerts - newser.com
Does Exagen Inc. show high probability of reboundNew Guidance & Safe Entry Point Alerts - newser.com
Exagen (NASDAQ:XGN) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
What analysts say about Exagen Inc stockMoving Average Crossovers & Affordable Investment Tips - earlytimes.in
Can Exagen Inc. recover in the next quarterBond Market & Weekly Momentum Stock Picks - newser.com
Exagen Inc. (NASDAQ:XGN) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Exagen Inc. recovery potential after sell offBond Market & Reliable Price Breakout Signals - newser.com
Exagen Inc Stock Analysis and ForecastBullish Engulfing Patterns & Small Budget Capital Investment - earlytimes.in
Exagen Inc. (XGN) Reports Q1 Loss, Tops Revenue Estimates - MSN
Is Exagen Inc. stock a bargain at current levelsQuarterly Investment Review & Real-Time Volume Spike Alerts - newser.com
Will Exagen Inc. (E08A) stock recover faster than industryMarket Sentiment Review & Real-Time Volume Trigger Notifications - newser.com
Is Exagen Inc. (E08A) stock supported by free cash flowJuly 2025 Levels & Technical Buy Zone Confirmations - newser.com
What drives Exagen Inc stock priceUtilities Sector Analysis & Crush the Market with Breakout Winners - earlytimes.in
With 38% stake, Exagen Inc. (NASDAQ:XGN) seems to have captured institutional investors' interest - Yahoo Finance
Can Exagen Inc. (E08A) stock test all time highs2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Exagen Inc Stock (XGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Exagen Inc Stock (XGN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Mar 25 '25 |
Sale |
3.30 |
350,000 |
1,155,000 |
1,758,958 |
| NMSIC Co-Investment Fund, L.P. | 10% Owner |
Nov 20 '24 |
Sale |
3.30 |
200,000 |
660,040 |
2,108,958 |
| Black Jeffrey G. | Chief Financial Officer |
Nov 15 '24 |
Buy |
2.98 |
22,298 |
66,448 |
274,492 |
| ABALLI JOHN | President and CEO |
Nov 14 '24 |
Buy |
2.81 |
24,305 |
68,297 |
689,799 |
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):